64 results
Page 3 of 4
SUPPL
nqe2una6e1rst3xd3bn
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
EX-99.3
thalw27l7rl079lajb
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.1
rk6q8 xdhsam3lo785m
6 Aug 19
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.2
q5196
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
7yh0j1qcx gn36p4v8i
14 May 19
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
4:02pm
40-F
EX-99.1
hcg pzfue8gf0x9pic
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.3
14qxxpoe1
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
b00xmx3057ihgx3nqk4c
19 Mar 19
Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
4:02pm
SUPPL
ryzoevznm9rwrkzbj
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.2
8rixe
8 Nov 18
Current report (foreign)
4:04pm
6-K
EX-99.1
md1wfq5sslyo14ifaxk
8 Nov 18
Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
4:02pm
6-K
EX-99.2
4iimo5 7opsdj2s
9 Aug 18
Current report (foreign)
4:05pm
6-K
EX-99.1
7ea8 osn5pcbc
9 Aug 18
Aurinia Reports Second Quarter Financial Results and Operational Highlights
4:03pm
6-K
EX-99.1
y7tdxz35gi9
25 Jun 18
Aurinia Initiates Clinical Trials Broadening the Development of Voclosporin
11:32am
6-K
EX-99.1
umvori0
22 Jun 18
Aurinia Announces Results of Annual General Meeting
4:30pm
6-K
EX-99.2
hq5f6e xwnf
10 May 18
Current report (foreign)
4:06pm
6-K
EX-99.1
5fn52b7p36xbs7cedzp
10 May 18
Aurinia Reports First Quarter Financial Results and Operational Highlights
4:03pm
6-K
EX-99.1
88udv5gp
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am
40FR12B/A
EX-99.15
5943kc56uprf9
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.26
7oq1uzd
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am